-
Mashup Score: 7A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells - 3 month(s) ago
CRISPR technologies have begun to revolutionize T cell therapies; however, conventional CRISPR-Cas9 genome-editing tools are limited in their safety, …
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists1Tweet
SCI members Stanley Qi, Crystal Mackall & others developed MEGA for versatile transcriptomic regulation in primary human T cells using #CRISPR Cas13d. https://t.co/8WkYGWjPbs @stanleyqilab @MackallLab #CARTcells https://t.co/pykzoDhHzT